BK Clinical Trials Consulting Holding ApS

CVR 37087858 · Private limited company (ApS) · Active · Low risk

BK Clinical Trials Consulting Holding ApS is a Private limited company (ApS), founded on , based in Nærum. The company is registered in the industry anden finansiel formidling i.a.n.. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.1 times the average for Danish companies. 10 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 7,117 and a net result of DKK -5,250. CEO: Bente Knap.

Bankruptcy risk for BK Clinical Trials Consulting Holding ApS

0.2%
probability of bankruptcy within 12 months
Low risk

0.1 × the average (1.41%) · higher risk than 44% of active Danish companies

Lowest riskHighest risk

Increases the risk

Going-concern uncertaintyYes · bankruptcy rate 16.3%1.9×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Equity vs. share capital0–0.5× · bankruptcy rate 11.1%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Share of late annual reports25%–50% · bankruptcy rate 10.6%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Time since new CEO5+ yrs · bankruptcy rate 3.8%0.43×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Negative equityNo · bankruptcy rate 5.1%0.58×
Capital changes2 · bankruptcy rate 5.2%0.59×
Auditor's statementCompilation · bankruptcy rate 5.6%0.64×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
37087858
Status
Active
Company type
Private limited company (ApS)
Founded
(11 years)
Address
Hegnsvej 44
2850 Nærum
Municipality
Rudersdal
Industry
Anden finansiel formidling i.a.n. (649990)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber
Share capital
DKK 20k
Auditor
Dansk Revision RoskildeGodkendt revisionsaktieselskab
Audit opted out
Yes

Warning signs

Annual reports filed late3 of 10
Missing annual reportNo
Negative equityNo
Equity ratio19.3%
Current ratio124%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address0
Going-concern uncertaintyYes

Financials and key figures

Financial year20252024
Net profitDKK -5,250DKK -6,000
EquityDKK 7,117DKK 12k
Total assetsDKK 37kDKK 37k
CashDKK 37k–
Short-term debtDKK 30k–
Avg. employees1–

Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Dansk Revision RoskildeGodkendt revisionsaktieselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025181
1 Jan 2024 – 31 Dec 2024176
1 Jan 2023 – 31 Dec 2023194 Late
1 Jan 2022 – 31 Dec 2022186 Late
1 Jan 2021 – 31 Dec 2021172
1 Jan 2020 – 31 Dec 2020183
1 Jan 2019 – 31 Dec 2019178
1 Jan 2018 – 31 Dec 2018153
1 Jan 2017 – 31 Dec 2017171
9 Sep 2015 – 31 Dec 2016160

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOBente KnapCurrent
Owner (100%)Bente KnapCurrent
FounderBente KnapCurrent

Address history (0 moves)

Hegnsvej 44, 2850 Nærum

Former names

BK Clinical Trials Consulting Holding ApS – now
BK Clinical Trials Consulting Holding IVS –

Similar companies in Rudersdal

Questions and answers about BK Clinical Trials Consulting Holding ApS

Has BK Clinical Trials Consulting Holding ApS gone bankrupt?

No, BK Clinical Trials Consulting Holding ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of BK Clinical Trials Consulting Holding ApS?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.

Who is the CEO of BK Clinical Trials Consulting Holding ApS?

Bente Knap is the CEO of BK Clinical Trials Consulting Holding ApS.

Who is the auditor of BK Clinical Trials Consulting Holding ApS?

BK Clinical Trials Consulting Holding ApS most recently used Dansk Revision RoskildeGodkendt revisionsaktieselskab.

When was BK Clinical Trials Consulting Holding ApS founded?

BK Clinical Trials Consulting Holding ApS was founded on 9 September 2015.

What is the equity of BK Clinical Trials Consulting Holding ApS?

Equity was DKK 7,117 according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.